Theranostics Health (TH; Rockville, Maryland) said that it has received a CLIA certificate of registration from the federal government. This, along with its medical laboratory permit from the State of Maryland Department of Health & Mental Hygiene, allows the company to perform clinical diagnostic laboratory testing in the disciplines/specialties of Immunology/protein microarray and pathology/histopathology.

"This represents another significant milestone for our young company in terms of building our capabilities. It allows us to expand the scope of services that we provide to our clients and collaborative projects that we conduct with our partners. It also allows us to accelerate the launch of our suite of clinical theranostic tests for personalized therapy," said President/CEO Danong Chen.

Theranostics' core technology is the Reverse Phase Protein Microarray combined with Laser Capture Microdissection.